XML 44 R37.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Segment Information (Tables)
6 Months Ended
Jun. 28, 2024
Segment Reporting [Abstract]  
Revenue, Gross Profit, Gross Profit Margin, Operating Income (Loss), and Depreciation and Amortization Expenses by Reportable Segment

Revenue, gross profit, gross profit margin, operating income (loss), and depreciation and amortization expenses by reportable segment were as follows (in thousands, except percentage data):

 

Three Months Ended

 

 

Six Months Ended

 

 

June 28,

 

 

June 30,

 

 

June 28,

 

 

June 30,

 

Revenue

2024

 

 

2023

 

 

2024

 

 

2023

 

Precision Medicine and Manufacturing

$

63,952

 

 

$

74,333

 

 

$

129,186

 

 

$

143,861

 

Medical Solutions

 

104,525

 

 

 

83,322

 

 

 

206,977

 

 

 

160,962

 

Robotics and Automation

 

67,387

 

 

 

71,809

 

 

 

130,617

 

 

 

143,767

 

Total

$

235,864

 

 

$

229,464

 

 

$

466,780

 

 

$

448,590

 

 

 

Three Months Ended

 

 

Six Months Ended

 

 

June 28,

 

 

June 30,

 

 

June 28,

 

 

June 30,

 

Gross Profit

2024

 

 

2023

 

 

2024

 

 

2023

 

Precision Medicine and Manufacturing

$

30,580

 

 

$

36,513

 

 

$

62,364

 

 

$

70,846

 

Medical Solutions

 

40,364

 

 

 

34,257

 

 

 

79,755

 

 

 

66,143

 

Robotics and Automation

 

33,388

 

 

 

34,909

 

 

 

63,937

 

 

 

67,724

 

Unallocated Corporate and Shared Services

 

(643

)

 

 

(1,556

)

 

 

(1,951

)

 

 

(2,962

)

Total

$

103,689

 

 

$

104,123

 

 

$

204,105

 

 

$

201,751

 

 

 

Three Months Ended

 

 

Six Months Ended

 

 

June 28,

 

 

June 30,

 

 

June 28,

 

 

June 30,

 

Gross Profit Margin

2024

 

 

2023

 

 

2024

 

 

2023

 

Precision Medicine and Manufacturing

 

47.8

%

 

 

49.1

%

 

 

48.3

%

 

 

49.2

%

Medical Solutions

 

38.6

%

 

 

41.1

%

 

 

38.5

%

 

 

41.1

%

Robotics and Automation

 

49.5

%

 

 

48.6

%

 

 

48.9

%

 

 

47.1

%

Total

 

44.0

%

 

 

45.4

%

 

 

43.7

%

 

 

45.0

%

 

 

 

Three Months Ended

 

 

Six Months Ended

 

 

June 28,

 

 

June 30,

 

 

June 28,

 

 

June 30,

 

Operating Income (Loss)

2024

 

 

2023

 

 

2024

 

 

2023

 

Precision Medicine and Manufacturing

$

12,744

 

 

$

19,611

 

 

$

28,488

 

 

$

36,295

 

Medical Solutions

 

12,276

 

 

 

10,083

 

 

 

24,265

 

 

 

19,924

 

Robotics and Automation

 

14,648

 

 

 

15,248

 

 

 

26,864

 

 

 

27,248

 

Unallocated Corporate and Shared Services

 

(13,953

)

 

 

(12,744

)

 

 

(28,295

)

 

 

(24,957

)

Total

$

25,715

 

 

$

32,198

 

 

$

51,322

 

 

$

58,510

 

 

 

Three Months Ended

 

 

Six Months Ended

 

 

June 28,

 

 

June 30,

 

 

June 28,

 

 

June 30,

 

Depreciation and Amortization Expenses

2024

 

 

2023

 

 

2024

 

 

2023

 

Precision Medicine and Manufacturing

$

2,453

 

 

$

2,661

 

 

$

4,815

 

 

$

5,257

 

Medical Solutions

 

7,235

 

 

 

4,044

 

 

 

13,325

 

 

 

8,017

 

Robotics and Automation

 

3,994

 

 

 

4,917

 

 

 

7,995

 

 

 

9,762

 

Unallocated Corporate and Shared Services

 

434

 

 

 

315

 

 

 

910

 

 

 

632

 

Total

$

14,116

 

 

$

11,937

 

 

$

27,045

 

 

$

23,668

 

Schedule of Geographic Revenue

The Company aggregates geographic revenue based on the customer locations where products are shipped to. Revenue by geography was as follows (in thousands):

 

Three Months Ended

 

 

Six Months Ended

 

 

June 28,

 

 

June 30,

 

 

June 28,

 

 

June 30,

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

United States

$

123,391

 

 

$

107,594

 

 

$

240,472

 

 

$

211,436

 

Germany

 

31,919

 

 

 

32,097

 

 

 

65,100

 

 

 

66,959

 

Rest of Europe

 

32,528

 

 

 

34,537

 

 

 

63,499

 

 

 

63,902

 

China

 

19,014

 

 

 

20,854

 

 

 

36,085

 

 

 

38,652

 

Rest of Asia-Pacific

 

25,334

 

 

 

27,390

 

 

 

52,590

 

 

 

55,501

 

Other

 

3,678

 

 

 

6,992

 

 

 

9,034

 

 

 

12,140

 

Total

$

235,864

 

 

$

229,464

 

 

$

466,780

 

 

$

448,590

 

Revenue By End Market

The Company primarily operates in two end markets: the medical market and the advanced industrial market. Revenue by end market was approximately as follows:

 

Three Months Ended

 

 

Six Months Ended

 

 

June 28,

 

 

June 30,

 

 

June 28,

 

 

June 30,

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Medical

 

58

%

 

 

53

%

 

 

57

%

 

 

53

%

Advanced Industrial

 

42

%

 

 

47

%

 

 

43

%

 

 

47

%

Total

 

100

%

 

 

100

%

 

 

100

%

 

 

100

%